TY - JOUR
T1 - Posterior reversible encephalopathy syndrome associated with Guillain-Barré syndrome
T2 - Case report and clinical management considerations
AU - Salvalaggio, Alessandro
AU - Cagnin, Annachiara
AU - Marson, Piero
AU - Ferracci, Franco
AU - Cortelli, Pietro
AU - Corbetta, Maurizio
AU - Briani, Chiara
N1 - Publisher Copyright:
© 2020 Wiley Periodicals, Inc.
PY - 2020/6/1
Y1 - 2020/6/1
N2 - Around half of the patients with Guillain-Barré syndrome (GBS) present autonomic dysfunction requiring admission to intensive care unit in up to a quarter of patients. Treatment of GBS consists of plasma exchange (PE) and intravenous immunoglobulins (IVIG). Posterior reversible encephalopathy syndrome (PRES) consists in a reversible subcortical vasogenic brain edema caused by endothelial damage triggered by abrupt blood pressure changes. We report on a woman who presented with PRES in the course of GBS treated first with IVIG, and then with PE. The present report underlines the challenge that the clinicians face when these two rare syndromes concur. The literature is not helpful considering that both blood pressure fluctuations and IVIG are reported to be involved in the pathogenesis of PRES. In the present letter, both pathogenic mechanisms and clinical management considerations are discussed.
AB - Around half of the patients with Guillain-Barré syndrome (GBS) present autonomic dysfunction requiring admission to intensive care unit in up to a quarter of patients. Treatment of GBS consists of plasma exchange (PE) and intravenous immunoglobulins (IVIG). Posterior reversible encephalopathy syndrome (PRES) consists in a reversible subcortical vasogenic brain edema caused by endothelial damage triggered by abrupt blood pressure changes. We report on a woman who presented with PRES in the course of GBS treated first with IVIG, and then with PE. The present report underlines the challenge that the clinicians face when these two rare syndromes concur. The literature is not helpful considering that both blood pressure fluctuations and IVIG are reported to be involved in the pathogenesis of PRES. In the present letter, both pathogenic mechanisms and clinical management considerations are discussed.
KW - Guillain-Barré syndrome
KW - dysautonomia
KW - intravenous immunoglobulins
KW - plasma exchange
KW - posterior reversible encephalopathy syndrome
UR - http://www.scopus.com/inward/record.url?scp=85083383738&partnerID=8YFLogxK
U2 - 10.1002/jca.21783
DO - 10.1002/jca.21783
M3 - Article
C2 - 32289176
AN - SCOPUS:85083383738
SN - 0733-2459
VL - 35
SP - 231
EP - 233
JO - Journal of Clinical Apheresis
JF - Journal of Clinical Apheresis
IS - 3
ER -